UCB (UCB S.A.)

UCB S.A. is a global biopharmaceutical company based in Belgium, focusing on developing and delivering innovative medicines for patients with serious diseases, particularly in neurology and immunology. Founded in 1928, UCB combines science and technology to create treatments that improve the quality of life for people with conditions like epilepsy, Crohn's disease, and rheumatoid arthritis. The company emphasizes research and development, collaborating with healthcare professionals to address unmet medical needs. UCB is dedicated to sustainability and operates in multiple countries, impacting healthcare positively across the globe.